vimarsana.com

Page 2 - மையம் க்கு உலகளாவிய தொற்று நோய் பகுப்பாய்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

COVID-19 antibodies persist after nine months

COVID-19 antibodies persist after nine months ANI 20 Jul 2021, 12:55 GMT+10 London [UK], July 20 (ANI): A new study led by researchers at Imperial College London and University of Padua shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic. The results of the study were published in the journal Nature Communications. Researchers tested more than 85 per cent of the 3,000 residents of Vo , Italy, in February/March 2020 for infection with SARS-CoV-2, the virus that causes COVID-19, and tested them again in May and November 2020 for antibodies against the virus. The team found that 98.8 per cent of people infected in February/March showed detectable levels of antibodies in November, and there was no difference between people who had suffered symptoms of COVID-19 and those that had been symptom-free.

Third wave of coronavirus unlikely to be as severe as second wave: Study

Third wave of coronavirus unlikely to be as severe as second wave: Study SECTIONS Last Updated: Jun 26, 2021, 10:00 AM IST Share Synopsis Considering the four hypotheses for the emergence of a third wave, the study said, infection-induced immunity may decay over time, permitting re-infection of those previously exposed, even if the circulating virus remains unchanged. Covid third wave unlikely to be as severe as the second wave: ICMR study A third wave of COVID-19 if it occurs is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country, according to a study. The study, based on mathematical modelling analysis published in the Indian Journal of Medical Research (IJMR), highlights that the emergence of a third wave of coronavirus could be substantially mitigated by the expansion of vaccination.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.